Literature DB >> 23368661

Liver toxicity due to olanzapine.

José Luis Domínguez-Jiménez, Juan Jesús Puente-Gutiérrez, Eva María Pelado-García, Diego Cuesta-Cubillas, Antonio Manuel García-Moreno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23368661     DOI： 10.4321/s1130-01082012001100017

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


× No keyword cloud information.
  5 in total

Review 1.  Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.

Authors:  Mahmoud Slim; Inmaculada Medina-Caliz; Andres Gonzalez-Jimenez; M Rosario Cabello; Fermin Mayoral-Cleries; M Isabel Lucena; Raul J Andrade
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.

Authors:  Robin H Schmidt; Jenny D Jokinen; Veronica L Massey; K Cameron Falkner; Xue Shi; Xinmin Yin; Xiang Zhang; Juliane I Beier; Gavin E Arteel
Journal:  J Pharmacol Exp Ther       Date:  2013-08-07       Impact factor: 4.030

3.  Escitalopram-induced liver injury: A case report and review of literature.

Authors:  Qin Xiang Ng; Christl Suet Kwan Yong; Wayren Loke; Wee Song Yeo; Alex Yu Sen Soh
Journal:  World J Hepatol       Date:  2019-10-27

4.  Escitalopram-induced hepatitis: A case report.

Authors:  Guillaume Wabont; Laurie Ferret; Nicolas Houdre; Antoine Lepied; Johana Bene; Etienne Cousein
Journal:  World J Clin Cases       Date:  2022-03-16       Impact factor: 1.337

Review 5.  Antidepressants- and antipsychotics-induced hepatotoxicity.

Authors:  Nevena Todorović Vukotić; Jelena Đorđević; Snežana Pejić; Neda Đorđević; Snežana B Pajović
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.